Wells Fargo notes that Cigna (CI) has abandoned deal talks with Humana (HUM), but reportedly continues to see merits to the deal. The firm expects the stock to react positively following recent weakness. The implications for Cigna’s MA business are unclear, says Wells, which remains skeptical Cigna would sell in a vacuum. The firm has an Equal Weight rating on the shares with a price target of $334.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CI:
- M & A News: Cigna (NYSE:CI) Dropped Humana Merger Plans
- Cigna call volume above normal and directionally bullish
- Cigna to reaffirm FY23 adjusted EPS view ‘at least’ $24.75, consensus $24.83
- JPMorgan managed care/facilities analyst holds analyst/industry conference call
- Cigna- Humana merger has significant long-term strategic merit, says Stephens
